Stable Isotopes- Adults With Obesity
Assessing Metabolic Health With Stable Isotope Tracer Techniques in Adults With Obesity
University of Illinois at Urbana-Champaign
8 participants
Sep 12, 2025
INTERVENTIONAL
Conditions
Summary
In a crossover design, 8 participants will receive caloric drinks containing stable isotopes. In one arm of the study, participants will consume 6 hourly drinks containing two stable isotopes. Repeated blood, breath, urine, and muscle biopsies will be taken. In the second arm, participants will consume 1 drink containing 75g glucose, labeled with two stable isotopes of glucose. Periodic blood and breath will be taken over three hours.
Eligibility
Inclusion Criteria3
- ages 19-59
- Obese >/= 30 kg/m\^2 and >/= 102 cm for males and >/= 88 cm for females
- Godin Leisure-time or exercise questionnaire <14 units
Exclusion Criteria7
- Pregnant or become pregnant
- Any known food allergies
- Smoker
- Are physically active
- Have any known metabolic diseases
- Have been weight unstable within the last 6 months (lost or gained >10% of body mass)
- Non eumenorrheic or on a hormonal birth control
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will ingest six hourly meals designed to provide 50% of the daily intake of 1.1 g·kgLBM. Additional energy (1.5x daily resting metabolic rate), carbohydrate (55%), and fat (35%) will be provided in beverages and protein-free cookies (for palatability). The first drink will contain priming doses of NaH13CO2 (0.176 mg·kg-1), \[13C\]phenylalanine (1.86 mg·kg-1), \[2H5\]phenylalanine (0.34 mg·kg-1) with all subsequent drinks containing 1.2 mg·kg-1 \[13C\]phenylalanine and 0.51 mg·kg-1 \[2H5\]phenylalanine.
Participants will consume a 75g glucose drink dissolved in 250 ml of water enriched with \[6,6\_2H2\]glucose and \[13C6\]glucose.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07020741